TIDMINHC
RNS Number : 9173R
Induction Healthcare Group PLC
11 July 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Distribution agreement for Induction Zesty with System C
Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that it
has signed a non-exclusive Software Reseller Agreement ('the
Agreement') with System C Healthcare Limited ('System C'), a
supplier of health and social care information technology systems
and services , for the Induction Zesty product in the UK.
Induction Zesty is a digital patient engagement portal that
enables end-to-end healthcare management. The portal's interface
provides a fully automated process for patients to manage their
hospital appointments, view their letters and clinical records, as
well as provide data remotely via digital questionnaires from a
smartphone.
System C specialises in providing health and social care
solutions across whole care communities. Their product portfolio
includes the CareFlow EPR, an electronic patient record system
('EPR'), which is currently used in 30 NHS Trusts across the UK. As
part of the agreement, System C will now actively sell Induction
Zesty into its new and existing customers using CareFlow EPR. The
non-exclusive agreement covers an initial three-year term with
automatic 12 month renewals thereafter.
NHS Trusts are looking for solutions which require minimum
procurement but provide maximum impact. System C is able to link
information from multiple systems to integrate workflows between
care settings and support multi-provider reporting and analysis. As
a result of this agreement, the procurement of Induction Zesty will
be easy and more accessible for NHS Trusts already using CareFlow
EPR and a proven, effective solution for new customers.
This comes at a time of significant national focus and spending
on digital transformation for NHS secondary care providers in
England, which is outlined in the NHS Long Term Plan(1) .
Digitisation, especially through EPRs, is even more important to
help tackle the backlog of elective care appointments following
COVID-19 and support NHS Trusts to meet the new Minimum Digital
Foundations requirements. System C has committed to providing
solutions to address all aspects of NHS Long Term Plan and with
500K unique users already, Induction Zesty is a secure solution to
support the government-led drive for patient portals in all UK
hospitals.
(1) https://www.longtermplan.nhs.uk/
Induction CEO, James Balmain, said: "We have a long-standing
relationship with System C, one of the largest domestic suppliers
of EPR software to the NHS, and it is a great step forward to be
formally partnered with them under a value-added reseller
agreement. Given System C's market share and their ability to reach
customers efficiently via their direct sales force, we expect to
see significant revenue generated via this partnership over the
coming years.
"Together with our value-added reseller agreement with Cerner
Corporation, we now have access to over 40% of Acute hospitals
through reseller agreements. This agreement with System C acts as
further material reinforcement of our strategy to partner with, and
build on top of, the key underlying systems used by hospitals."
Guy Lucchi, Managing Director of Healthcare at System C, said:
"We are very pleased to be partnering with Induction. The Zesty
patient portal is a welcome addition to our integrated EPR offering
which will empower patients to receive and view their clinical
appointment bookings and letters as well as reschedule and cancel
appointments within the portal, via a direct link to CareFlow
EPR."
- ENDS-
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd +44 (0)20 7933 8780 or induction@walbrookpr.com
Alice Woodings / Paul McManus Mob: +44 (0)7407 804 654 / +44
(0)7980 541 893
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions through a single integrated platform that transforms care
delivery. Our system-wide applications help healthcare providers
and administrators to deliver care at any stage remotely as well as
face-to-face - giving the communities they serve greater
flexibility, control and ease of access . Purpose-built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
About System C Healthcare Limited - www.systemc.com
System C is a British technology company that has been
supporting the NHS and social care for almost forty years. The
organisation is a leading supplier in acute EPRs with 30 NHS
Trusts. We are also the number one supplier in child health, a
pioneer in electronic observations with over 38 Trusts using our
systems, the fastest growing supplier in social care with 60% of
councils and the market leader in hospital pharmacy and medicines
management where we support GBP5bn+ medications per year across
350+ hospitals. Plus, we are the national provider of the COVID and
flu vaccination system, NIMS.
Our Care Alliance partner, Graphnet, is the number one supplier
in shared care records holding data on over 20m citizens, the
number one supplier in population health analytics with over 17.3m
citizens covered and provides remote monitoring to over 50,000
citizens.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRFZGGNVRLGZZM
(END) Dow Jones Newswires
July 11, 2022 02:00 ET (06:00 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024